Financhill
Buy
52

OJIPF Quote, Financials, Valuation and Earnings

Last price:
$5.26
Seasonality move :
4.07%
Day range:
$5.26 - $5.26
52-week range:
$3.78 - $5.26
Dividend yield:
3.81%
P/E ratio:
23.36x
P/S ratio:
0.40x
P/B ratio:
0.68x
Volume:
--
Avg. volume:
2
1-year change:
39.15%
Market cap:
$4.8B
Revenue:
$12.1B
EPS (TTM):
$0.23
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $12.8B $13.1B $12.6B $11.7B $12.1B
Revenue Growth (YoY) -- 2.1% -3.74% -6.85% 3.41%
 
Cost of Revenues $9.8B $10.1B $10.1B $9.5B $9.9B
Gross Profit $3B $3B $2.5B $2.2B $2.2B
Gross Profit Margin 23.63% 23.01% 19.57% 18.74% 18.32%
 
R&D Expenses $91.5M $82M $69M $72M $88.4M
Selling, General & Admin $2.3B $2B $1.9B $1.7B $1.8B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.2B $1.9B $1.8B $1.7B $1.8B
Operating Income $799.5M $1.1B $625.9M $502.1M $444M
 
Net Interest Expenses $64M $59.6M $46.6M $46.8M $56.2M
EBT. Incl. Unusual Items $762.6M $1.2B $624.4M $536.6M $553.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $275.2M $328M $195.4M $174.8M $238.9M
Net Income to Company $762.6M $1.2B $624.4M $536.6M $553.4M
 
Minority Interest in Earnings $19.4M $43.5M $12.2M $10.4M $11.6M
Net Income to Common Excl Extra Items $487.5M $822.3M $429M $361.8M $314.5M
 
Basic EPS (Cont. Ops) $0.47 $0.79 $0.42 $0.35 $0.31
Diluted EPS (Cont. Ops) $0.47 $0.79 $0.42 $0.35 $0.31
Weighted Average Basic Share $990.2M $990.5M $991M $990.2M $975.4M
Weighted Average Diluted Share $990.8M $991M $991.4M $990.5M $975.6M
 
EBITDA $1.4B $1.7B $1.2B $1.1B $1.1B
EBIT $799.5M $1.1B $625.9M $502.1M $444M
 
Revenue (Reported) $12.8B $13.1B $12.6B $11.7B $12.1B
Operating Income (Reported) $799.5M $1.1B $625.9M $502.1M $444M
Operating Income (Adjusted) $799.5M $1.1B $625.9M $502.1M $444M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $3.3B $3.2B $3B $3.2B $3.1B
Revenue Growth (YoY) 6.7% -4.64% -6.83% 10.04% -4.49%
 
Cost of Revenues $2.5B $2.5B $2.4B $2.6B $2.5B
Gross Profit $813.6M $648.3M $564.8M $644.1M $566.6M
Gross Profit Margin 24.48% 20.46% 19.13% 19.83% 18.26%
 
R&D Expenses $19.4M $15.1M $14.8M -- --
Selling, General & Admin $490M $468.9M $446.9M $491.9M $478.2M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $490M $468.9M $446.9M $491.9M $478.2M
Operating Income $323.6M $179.4M $117.9M $152.1M $88.3M
 
Net Interest Expenses $16M $11.5M $11.4M $17M $18.5M
EBT. Incl. Unusual Items $308.2M $176.9M $153M $89.2M $157.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $81.8M $67.6M $54.2M $42.1M $45.2M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$390.6K $3.4M $1.6M $3.5M $3.2M
Net Income to Common Excl Extra Items $226.5M $109.2M $98.8M $47.1M $112.2M
 
Basic EPS (Cont. Ops) $0.23 $0.11 $0.10 $0.04 $0.12
Diluted EPS (Cont. Ops) $0.23 $0.11 $0.10 $0.04 $0.12
Weighted Average Basic Share $990.6M $990.7M $991.3M $984.7M $913M
Weighted Average Diluted Share $991M $991.5M $991.3M $984.7M $923.3M
 
EBITDA $467.3M $312.2M $262.7M $310.3M $249.9M
EBIT $323.6M $179.4M $117.9M $152.1M $88.3M
 
Revenue (Reported) $3.3B $3.2B $3B $3.2B $3.1B
Operating Income (Reported) $323.6M $179.4M $117.9M $152.1M $88.3M
Operating Income (Adjusted) $323.6M $179.4M $117.9M $152.1M $88.3M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $13.2B $12.9B $12.4B $11.8B $12.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $9.9B $10.1B $9.9B $9.6B $10.1B
Gross Profit $3.3B $2.7B $2.5B $2.2B $2.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $91.3M $73.4M $68.1M -- --
Selling, General & Admin $2.2B $1.9B $1.9B $1.8B $1.9B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.2B $1.9B $1.8B $1.8B $1.9B
Operating Income $1.1B $790.8M $603.8M $473.3M $313.8M
 
Net Interest Expenses $66.5M $54.1M $45.5M $51M $63.1M
EBT. Incl. Unusual Items $1.2B $966M $557.4M $462.3M $410.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $342M $291.8M $180.5M $167M $182.7M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings $44M $24.3M $12.3M $8.5M $10.2M
Net Income to Common Excl Extra Items $832.4M $674.1M $376.9M $295.2M $227.5M
 
Basic EPS (Cont. Ops) $0.80 $0.66 $0.37 $0.29 $0.23
Diluted EPS (Cont. Ops) $0.80 $0.66 $0.37 $0.29 $0.23
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $1.7B $1.4B $1.2B $1B $965.9M
EBIT $1.1B $790.8M $603.8M $473.3M $313.8M
 
Revenue (Reported) $13.2B $12.9B $12.4B $11.8B $12.3B
Operating Income (Reported) $1.1B $790.8M $603.8M $473.3M $313.8M
Operating Income (Adjusted) $1.1B $790.8M $603.8M $473.3M $313.8M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $6.5B $6.2B $6B $6.1B $6.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $4.9B $5B $4.8B $4.9B $5.2B
Gross Profit $1.6B $1.2B $1.2B $1.2B $1.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $41.9M $33.3M $32.4M -- --
Selling, General & Admin $992.3M $943.5M $910.7M $930.3M $967.6M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $992.3M $943.5M $910.7M $930.3M $967.6M
Operating Income $580.1M $299.4M $276.2M $245.4M $114M
 
Net Interest Expenses $31M $25.5M $24.4M $28.5M $35.3M
EBT. Incl. Unusual Items $618M $431.2M $355.7M $275.9M $134.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $175.6M $138.2M $123M $113.1M $57.5M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings $27.2M $7.7M $7.6M $5.5M $4M
Net Income to Common Excl Extra Items $442.4M $292.9M $232.7M $162.8M $77.4M
 
Basic EPS (Cont. Ops) $0.42 $0.29 $0.23 $0.16 $0.08
Diluted EPS (Cont. Ops) $0.42 $0.29 $0.23 $0.16 $0.08
Weighted Average Basic Share $2B $2B $2B $2B $1.8B
Weighted Average Diluted Share $2B $2B $2B $2B $1.8B
 
EBITDA $865.4M $564.5M $560.6M $534M $435.8M
EBIT $580.1M $299.4M $276.2M $245.4M $114M
 
Revenue (Reported) $6.5B $6.2B $6B $6.1B $6.3B
Operating Income (Reported) $580.1M $299.4M $276.2M $245.4M $114M
Operating Income (Adjusted) $580.1M $299.4M $276.2M $245.4M $114M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $1.2B $459.9M $428.8M $415.3M $440.4M
Short Term Investments $51.9M $90.7M $47.3M $31.5M $49.7M
Accounts Receivable, Net $2.7B $2.7B $2.8B $2.4B $2.5B
Inventory $1.8B $1.9B $2.1B $1.9B $2.1B
Prepaid Expenses -- -- -- -- --
Other Current Assets $145.6M $139.4M $262.2M $160.7M $130.7M
Total Current Assets $6.1B $5.3B $5.9B $5.1B $5.4B
 
Property Plant And Equipment $9.4B $9.3B $9.1B $8.4B $9.2B
Long-Term Investments $1.5B $1.4B $1.4B $1.5B $1.3B
Goodwill $28.3M $28.4M $89.1M $119.5M $389.6M
Other Intangibles $82M $66.2M $106M $108.2M $348.9M
Other Long-Term Assets $148.9M $173M $187.2M $203M $222.2M
Total Assets $17.9B $16.9B $17.3B $16.1B $17.6B
 
Accounts Payable $1.8B $1.9B $1.9B $1.8B $1.8B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $296.1M $260.7M $274.6M $266.6M $234.8M
Total Current Liabilities $4B $4.4B $5.2B $4.4B $4.9B
 
Long-Term Debt $4.9B $4.2B $3.7B $3.3B $3.9B
Capital Leases -- -- -- -- --
Total Liabilities $10.1B $9.7B $10B $8.9B $10B
 
Common Stock $940.1M $855.9M $780.5M $686.4M $694.7M
Other Common Equity Adj -- -- -- -- --
Common Equity $6.8B $7B $7B $7B $7.4B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1B $198.4M $206.5M $191.9M $207.1M
Total Equity $7.8B $7.2B $7.2B $7.2B $7.6B
 
Total Liabilities and Equity $17.9B $16.9B $17.3B $16.1B $17.6B
Cash and Short Terms $1.2B $459.9M $428.8M $415.3M $440.4M
Total Debt $4.9B $4.7B $4.3B $3.9B $4.6B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $952.5M $404.3M $655.3M $806.7M $390.9M
Short Term Investments $117.8M $51.4M $37.8M $49.7M --
Accounts Receivable, Net $2.7B $2.6B $2.5B $2.7B $2.6B
Inventory $1.9B $1.9B $2B $2.2B $2.1B
Prepaid Expenses -- -- -- -- --
Other Current Assets $343M $327.6M $328.7M $369.4M --
Total Current Assets $6B $5.2B $5.5B $6.1B $5.4B
 
Property Plant And Equipment $9.7B $8.4B $8.5B $9.6B $9.1B
Long-Term Investments $1.5B $1.2B $1.3B $1.5B $1.4B
Goodwill $25.9M $130.8M $130.6M $604.5M --
Other Intangibles $68.2M $53.9M $103.7M $190.5M --
Other Long-Term Assets $863.6M $722.7M $655.8M $1B --
Total Assets $18.2B $15.7B $16.2B $19B $17.4B
 
Accounts Payable $1.9B $1.8B $1.8B $1.8B $1.6B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $819.3M $707.1M $694.6M $796.2M --
Total Current Liabilities $4.3B $4.5B $4.5B $5.8B $4.8B
 
Long-Term Debt $4.8B $3.3B $3.5B $3.4B $4.1B
Capital Leases -- -- -- -- --
Total Liabilities $10.6B $9B $9.1B $10.7B $10.2B
 
Common Stock $931M $717.7M $696.1M $726.2M $703.4M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $434.1M $177.9M $191.6M $215.7M $214.1M
Total Equity $7.6B $6.8B $7B $8.4B $7.2B
 
Total Liabilities and Equity $18.2B $15.7B $16.2B $19B $17.4B
Cash and Short Terms $952.5M $404.3M $655.3M $806.7M $390.9M
Total Debt $4.8B $3.3B $3.5B $3.6B $4.2B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $762.6M $1.2B $624.4M $536.6M $553.4M
Depreciation & Amoritzation $602.1M $593.5M $546.7M $565.6M $618.3M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $17.6M -$186.5M -$323.9M $121M $72.9M
Change in Inventories $190.1M -$231.4M -$314.5M $60.2M -$70.2M
Cash From Operations $1.2B $1.3B $134.8M $1.4B $619.3M
 
Capital Expenditures $892.7M $878M $694.4M $795.4M $944.1M
Cash Acquisitions -- $12.8M $242.5M $87.6M $385.1M
Cash From Investing -$863.3M -$823.8M -$909.7M -$816.1M -$1B
 
Dividends Paid (Ex Special Dividend) $130.9M $123.6M $109.8M $109.9M $129.4M
Special Dividend Paid
Long-Term Debt Issued $1.4B $231.6M $478.8M $607.6M $1.2B
Long-Term Debt Repaid -$596.7M -$46.5M -$443.5M -$523.2M -$565.2M
Repurchase of Common Stock $227.8M $685.2M -- $33.2M $192.2M
Other Financing Activities -$16.7M -$320.2M -$3.7M -$9.3M -$4.8M
Cash From Financing $187.9M -$1.2B $751.1M -$587.1M $399.9M
 
Beginning Cash (CF) $1.2B $457M $427M $412.8M $438.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $502.7M -$714.5M $10.4M $24.2M $19.9M
Ending Cash (CF) $1.7B -$215.7M $471.7M $461.3M $474.8M
 
Levered Free Cash Flow $305.8M $399.8M -$559.7M $607.7M -$324.8M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) $946.8M $402.1M $599.2M $802.3M $386M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2007-12-31 2008-12-31 2009-12-31 2010-12-31 2011-12-31
Net Income to Stockholders -- -- $184.9M $513.6M --
Depreciation & Amoritzation -- -- $995M $964.9M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- $261.2M $346.8M --
Change in Inventories -- -- $341.1M -$59.9M --
Cash From Operations $1.2B -- $1.5B $1.5B --
 
Capital Expenditures $762.4M $236.3M $1.1B $794.9M $253.8M
Cash Acquisitions -- -- -- $171.6M --
Cash From Investing -$1B -$534.7M -$1.1B -$1B --
 
Dividends Paid (Ex Special Dividend) -- -- $102.3M $118.9M $4.9M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$693.7M --
Repurchase of Common Stock -- -- $1.3M $1.3M --
Other Financing Activities -- -- -- -$8.3M --
Cash From Financing $210.8M $548.8M -$765.1M -$600.2M --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -$424.2M -$145.8M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $473.1M -- $361.8M $733.8M --
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) $1.9B $834.2M $1.1B $1.6B $864.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
72
KYMR alert for Dec 8

Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock